Neuropsychopharmacology
- The why, when, where, how, and so what of so-called rapidly acting antidepressants1 year ago
- In memoriam: S. J. Enna, PhD, December 19, 1944–June 15, 20231 year ago
- CB1R blockade unmasks TRPV1-mediated contextual fear generalization in female, but not male rats1 year ago
- Chemogenetic activation of corticotropin-releasing factor-expressing neurons in the anterior bed nucleus of the stria terminalis reduces effortful motivation behaviors1 year ago
- Potentiation of AMPA receptors for rapid therapeutic gain in psychiatry has reached a new level of excitement1 year ago
- Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication1 year ago
- A non-human primate model of cocaine addiction: interpreting associations with increased vs. decreased dopamine function1 year ago
Journal of Psychopharmacology
- Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis3 years ago
- Dopaminergic and noradrenergic modulation of stress-induced alterations in brain activation associated with goal-directed behaviour3 years ago
- Three regulatory compliant test systems show no signs of MDMA-related genotoxicity3 years ago
- Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group3 years ago
- Which are the demographic and clinical characteristics of patients who respond to subcutaneous esketamine?3 years ago
- Effects of benzodiazepine and orexin receptor antagonist on cognitive function revealed by auditory event-related potentials3 years ago
- The Journal of Psychopharmacology: La Plus ça change. . .3 years ago
European Neuropsychopharmacology
- Social Stress in Bipolar Disorder2 years ago
- Letter to the editor about the article “Psychiatric disorders in post-acute COVID-syndrome 3 (PDPACS): Recommendations for health care professionals” (Falconi A et al., 2022)2 years ago
- Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial2 years ago
- The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations2 years ago
- Depression, antidepressants, and insulin resistance: which link?2 years ago
- Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study2 years ago
- Association between CACNA1C gene rs100737 polymorphism and glutamatergic neurometabolites in bipolar disorder2 years ago